RE:RE:RE:How the heck….MM - your math is always impeccable so I'm sure it's correct. They did say the upcoming flu season - expected to be very pervasive - will provide the required cases in the trial sites. And 42 isn't a big number in the context of 14 and then 18 sites. Flu season will produce enough cases (look at Australia) and I expect GREED will capture them pronto for Tigris.
More interesting is what the undisclosed change to the Interim Deal is with Baxter. The US$2.5 mill of convertible paper became an adjustment to that part of the deal. NO DISCLOSURE - that is shameful from a governance perspective. Especially since lots of them loaded up disproportionately to past participation from this equity issue.